Mitochondrial insights on antidiabetic therapies: Differential impacts of SGLT2i, GLP-1, and insulin
Saved in:
Main Authors: | Yu-Hsiang Lin, Kuo-Hsuan Chang, Yu-Jen Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Pharmacological Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825000350 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The interplay of aging, sleep dysregulation, and mitochondrial dysfunction in metabolic and neurodegenerative diseases
by: Kuo-Jen Lin, et al.
Published: (2025-02-01) -
Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes
by: Bethany Murphy, et al.
Published: (2025-01-01) -
Evaluating the Effect on Total Daily Insulin Dose in Adult Patients with Type 1 Diabetes Managed with Metformin and/or GLP-1 or GLP-1/GIP Receptor Agonists
by: Mayeesha Ahmed, et al.
Published: (2025-02-01) -
Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease
by: Tian Meng, et al.
Published: (2025-02-01) -
Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbursement drug list in China.
by: Dunming Xiao, et al.
Published: (2025-01-01)